231 related articles for article (PubMed ID: 37993001)
1. Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity.
Zhang S; Zhang X; Yang H; Liang T; Bai X
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189022. PubMed ID: 37993001
[TBL] [Abstract][Full Text] [Related]
2. Manipulating T-cell metabolism to enhance immunotherapy in solid tumor.
Chen C; Wang Z; Ding Y; Qin Y
Front Immunol; 2022; 13():1090429. PubMed ID: 36618408
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumor microenvironment on adoptive T cell transfer activity.
Martín-Otal C; Navarro F; Casares N; Lasarte-Cía A; Sánchez-Moreno I; Hervás-Stubbs S; Lozano T; Lasarte JJ
Int Rev Cell Mol Biol; 2022; 370():1-31. PubMed ID: 35798502
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Antigen Receptors for the Tumour Microenvironment.
Habib R; Nagrial A; Micklethwaite K; Gowrishankar K
Adv Exp Med Biol; 2020; 1263():117-143. PubMed ID: 32588326
[TBL] [Abstract][Full Text] [Related]
5. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
Front Immunol; 2021; 12():645242. PubMed ID: 33815400
[TBL] [Abstract][Full Text] [Related]
6. Microenvironment-driven metabolic adaptations guiding CD8
Park J; Hsueh PC; Li Z; Ho PC
Immunity; 2023 Jan; 56(1):32-42. PubMed ID: 36630916
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming T-cell metabolism to enhance adoptive cell therapies.
Kates M; Saibil SD
Int Immunol; 2024 Apr; 36(6):261-278. PubMed ID: 38364321
[TBL] [Abstract][Full Text] [Related]
8. Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.
Kouidhi S; Ben Ayed F; Benammar Elgaaied A
Front Immunol; 2018; 9():353. PubMed ID: 29527212
[TBL] [Abstract][Full Text] [Related]
9. Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance.
Weng CY; Kao CX; Chang TS; Huang YH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514004
[TBL] [Abstract][Full Text] [Related]
10. Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy.
Li H; Zhao A; Li M; Shi L; Han Q; Hou Z
Front Immunol; 2022; 13():1046755. PubMed ID: 36569893
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect engagement of dendritic cell function by antibodies developed for cancer therapy.
Corogeanu D; Diebold SS
Clin Exp Immunol; 2022 Jul; 209(1):64-71. PubMed ID: 35352109
[TBL] [Abstract][Full Text] [Related]
12. Metabolic barriers to cancer immunotherapy.
DePeaux K; Delgoffe GM
Nat Rev Immunol; 2021 Dec; 21(12):785-797. PubMed ID: 33927375
[TBL] [Abstract][Full Text] [Related]
13. Remodeling metabolic fitness: Strategies for improving the efficacy of chimeric antigen receptor T cell therapy.
Shen L; Xiao Y; Tian J; Lu Z
Cancer Lett; 2022 Mar; 529():139-152. PubMed ID: 35007698
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy.
Guerra L; Bonetti L; Brenner D
Cell Rep; 2020 Jul; 32(1):107848. PubMed ID: 32640218
[TBL] [Abstract][Full Text] [Related]
15. Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy.
Chen S; Duan H; Sun G
Biomed Pharmacother; 2023 Aug; 164():114963. PubMed ID: 37269814
[TBL] [Abstract][Full Text] [Related]
16. Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.
Davern M; Donlon NE; O'Connell F; Gaughan C; O'Donovan C; McGrath J; Sheppard AD; Hayes C; King R; Temperley H; MacLean M; Bulter C; Bhardwaj A; Moore J; Donohoe C; Ravi N; Conroy MJ; Reynolds JV; Lysaght J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5377-5395. PubMed ID: 36445478
[TBL] [Abstract][Full Text] [Related]
17. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
18. Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes.
Nanjireddy PM; Olejniczak SH; Buxbaum NP
Front Immunol; 2023; 14():1121565. PubMed ID: 36999013
[TBL] [Abstract][Full Text] [Related]
19. Targeting metabolism of breast cancer and its implications in T cell immunotherapy.
Zou J; Mai C; Lin Z; Zhou J; Lai G
Front Immunol; 2024; 15():1381970. PubMed ID: 38680483
[TBL] [Abstract][Full Text] [Related]
20. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.
Li X; Wenes M; Romero P; Huang SC; Fendt SM; Ho PC
Nat Rev Clin Oncol; 2019 Jul; 16(7):425-441. PubMed ID: 30914826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]